{
  "run_id": "RUN_20260204_132700_1fed028ce5fb",
  "timestamp": "2026-02-04T16:29:52.295456",
  "document": "07_20251213-56068-pwzol9.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/PAPERS/07_20251213-56068-pwzol9.pdf",
  "pipeline_version": "0.8",
  "total_candidates": 4,
  "total_validated": 4,
  "total_rejected": 0,
  "total_investigational": 2,
  "drugs": [
    {
      "matched_text": "general anesthesia",
      "preferred_name": "General anesthesia",
      "brand_name": null,
      "compound_id": null,
      "confidence": 0.85,
      "is_investigational": true,
      "drug_class": null,
      "mechanism": null,
      "development_phase": "RECRUITING",
      "sponsor": null,
      "conditions": [
        "Bilateral",
        "Ultrasound",
        "Intramuscular Quadratus Lumborum Plane Block",
        "Lateral Quadratus Lumborum Plane Block",
        "Postoperative Pain",
        "Cancer Patients",
        "Open Nephrectomy"
      ],
      "nct_id": "NCT06889987",
      "dosage_form": null,
      "route": null,
      "marketing_status": null,
      "codes": {
        "rxcui": null,
        "mesh": null,
        "ndc": null,
        "drugbank": null,
        "unii": null
      },
      "all_identifiers": [
        {
          "system": "NCT",
          "code": "NCT06889987",
          "display": null
        }
      ],
      "context": "OvDEc4Z97CC\n\nIntervention\n\nGiven the significant shunt (Qp/Qs >1.5) and evidence of right-heart dilation, percutaneous closure was recommended. Under general anesthesia and fluoroscopic-TEE guidance, an occluder device was successfully deployed across the defect (Video 2). Post-procedure imaging demonstrated immediat",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_investigational_drugs.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    },
    {
      "matched_text": "aspirin",
      "preferred_name": "Aspirin",
      "brand_name": null,
      "compound_id": null,
      "confidence": 0.85,
      "is_investigational": true,
      "drug_class": null,
      "mechanism": null,
      "development_phase": "RECRUITING",
      "sponsor": null,
      "conditions": [
        "Colorectal Cancer",
        "Colon Cancer"
      ],
      "nct_id": "NCT05036109",
      "dosage_form": null,
      "route": null,
      "marketing_status": null,
      "codes": {
        "rxcui": null,
        "mesh": "D001241",
        "ndc": null,
        "drugbank": null,
        "unii": null
      },
      "all_identifiers": [
        {
          "system": "NCT",
          "code": "NCT05036109",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D001241",
          "display": "Aspirin"
        }
      ],
      "context": "opic view of atrial septal defect device deployment\n\nView video here: https://youtu.be/390YyOW97tc?si=VS356rM8OeHOcyxX\n\nThe patient was discharged on aspirin therapy for three months and advised a gradual return to training. Follow-up at one and three months confirmed appropriate device positioning and reg",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_investigational_drugs.json",
      "validation_flags": [
        "auto_validated_lexicon",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "resolvin D1",
        "Aspirin Dipyridamole Drug Combination"
      ],
      "pubtator_normalized_name": "Aspirin",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "resource",
      "preferred_name": "RESOURCE",
      "brand_name": null,
      "compound_id": null,
      "confidence": 0.7,
      "is_investigational": false,
      "drug_class": null,
      "mechanism": null,
      "development_phase": null,
      "sponsor": null,
      "conditions": [],
      "nct_id": null,
      "dosage_form": null,
      "route": null,
      "marketing_status": null,
      "codes": {
        "rxcui": null,
        "mesh": "C518516",
        "ndc": null,
        "drugbank": null,
        "unii": null
      },
      "all_identifiers": [
        {
          "system": "RxCUI",
          "code": "711274",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "C518516",
          "display": "ENA Actimineral Resource A"
        }
      ],
      "context": "erse events over a median follow-up of 3.5 years [6]. This favourable safety profile has also been reproduced in diverse clinical contexts, including resource-limited settings, where acute complications such as device embolization or atrioventricular valve interference remain similarly uncommon [8]. Further",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_lexicon_drug.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": "ENA Actimineral Resource A",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "valve",
      "preferred_name": "VALVE",
      "brand_name": null,
      "compound_id": null,
      "confidence": 0.7,
      "is_investigational": false,
      "drug_class": null,
      "mechanism": null,
      "development_phase": null,
      "sponsor": null,
      "conditions": [],
      "nct_id": null,
      "dosage_form": null,
      "route": null,
      "marketing_status": null,
      "codes": {
        "rxcui": null,
        "mesh": null,
        "ndc": null,
        "drugbank": null,
        "unii": null
      },
      "all_identifiers": [
        {
          "system": "RxCUI",
          "code": "812659",
          "display": null
        }
      ],
      "context": "produced in diverse clinical contexts, including resource-limited settings, where acute complications such as device embolization or atrioventricular valve interference remain similarly uncommon [8]. Furthermore, more recent data have extended these findings by demonstrating that percutaneous closure rem",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_lexicon_drug.json",
      "validation_flags": [
        "lexicon_match",
        "deduplicated"
      ],
      "mesh_aliases": [],
      "pubtator_normalized_name": null,
      "enrichment_source": null
    }
  ]
}